Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. AZN
8. QQQ
9. USO
10. SEDG

Go back to Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
(NASDAQ: ABUS) Delayed: 5.12 --0 (-0%)
Previous Close $5.12    52 Week High $5.88 
Open $5.12    52 Week Low $2.65 
Day High $5.12    P/E N/A 
Day Low $5.12    EPS $0.00 
Volume 2       

(NASDAQ: ABUS) Delayed: 5.12 --0 (-0%)
Previous Close $5.12    52 Week High $5.88 
Open $5.12    52 Week Low $2.65 
Day High $5.12    P/E N/A 
Day Low $5.12    EPS $0.00 
Volume 2